SEC Fines Zymergen $30M Over Misleading Pre-IPO Claims

By Law360 Staff · September 13, 2024, 4:48 PM EDT

Now-shuttered biotechnology company Zymergen Inc. has agreed to pay a $30 million fine to settle U.S. Securities and Exchange Commission allegations that it misled investors in its initial public offering when...

To view the full article, register now.